Comparative Pharmacology
Head-to-head clinical analysis: MAGNESIUM SULFATE IN PLASTIC CONTAINER versus POTASSIUM CHLORIDE 0 037 IN DEXTROSE 10 AND SODIUM CHLORIDE 0 9 IN PLASTIC CONTAINER.
Peer-Reviewed Evidence
Head-to-head clinical analysis: MAGNESIUM SULFATE IN PLASTIC CONTAINER versus POTASSIUM CHLORIDE 0 037 IN DEXTROSE 10 AND SODIUM CHLORIDE 0 9 IN PLASTIC CONTAINER.
MAGNESIUM SULFATE IN PLASTIC CONTAINER vs POTASSIUM CHLORIDE 0.037% IN DEXTROSE 10% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Magnesium sulfate causes decreased release of acetylcholine at the neuromuscular junction, reducing muscle contractility. It also blocks calcium channels, leading to vasodilation and anticonvulsant effects.
Potassium chloride replaces potassium ions lost from the body; dextrose provides caloric supplementation and prevents ketosis; sodium chloride maintains electrolyte balance and hydration.
IV: 1-4 g as a 10-20% solution, rate not exceeding 1 g/min; for eclampsia: 4-5 g IV bolus then 1-2 g/hour IV infusion.
Intravenous infusion of 0.037% potassium chloride in 10% dextrose and 0.9% sodium chloride. The typical adult dose is 500-1000 mL as a continuous infusion at a rate of 1-2 mL/min (equivalent to 0.37-0.74 mg/min potassium chloride), adjusted based on serum potassium levels, with maximum infusion rate of 10 mEq/h potassium and daily maximum of 200 mEq potassium. Frequency: continuous infusion as needed.
None Documented
None Documented
Normal renal function: 4–6 hours (terminal). In oliguria or anuria, half-life may extend to >24 hours, requiring dose adjustment.
Potassium: terminal half-life ~2-3 hours in plasma, but whole-body turnover is slower; clinical context: dosing intervals depend on renal function and serum K+ monitoring. Dextrose: rapidly cleared, half-life <15 minutes. Sodium: not applicable as steady-state regulated by renal function.
Primarily renal (glomerular filtration); >90% excreted unchanged in urine. Biliary/fecal elimination is negligible (<1%).
Potassium: renal excretion (90-95%), with minor fecal (<5%) and negligible biliary elimination. Dextrose: primarily metabolized to CO2 and water. Sodium: renal excretion (95-100%) with minor fecal loss.
Category C
Category A/B
Electrolyte
Electrolyte